Recent advances in the non-surgical management of atrial fibrillation

International Journal of Clinical Practice

Volumn 53, Issue 1, 1999, Pages 44-49

  Kamalvand, K ^a   Sulke, N ^b  

^a WILLIAM HARVEY HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGOXIN; FLECAINIDE; PROPAFENONE; QUINIDINE; SOTALOL;

CARDIOVERSION; CATHETER ABLATION; DEFIBRILLATION; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HUMAN; IMPLANTATION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SINUS RHYTHM;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CATHETER ABLATION; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0033043859     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Hill JD, Mottram EM, Killeen PD et al. Study of the prevalence of atrial fibrillation in general practice patients over 65 years of age. J Roy Coll Gen Pract 1987; 37: 172-173.
2. Kannel WB, Abbott RD, Savage DD et al. Epidemiological features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982; 306: 1018-1022.
3. Bialy D, Lehman MH, Schumacher DN et al. Hospitalisation for arrhythmias in the United States: importance of atrial fibrillation (abstract). J Am Coll Cardiol 1992; 19:41.
4. Wolf PA, Abbott RD, Kannel WB et al. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 1991; 22: 983-988.
5. Moe GK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962; 140: 183-188.
6. Morillo CA, Klein GJ, Jones DL et al. Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995; 91: 1588-1595.
7. Wijffels M, Kirchof C, Fredericks J et al. Atrial fibrillation begets atrial fibrillation (abstract). Circulation 1988: 4(11): 1-18.
8. Kumagai K, Akimitsu S, Kawahira K et al. Electrophysiological properties in chronic lone atrial fibrillation. Circulation 1991; 84: 1662-1668.
9. Theiss W. Anticoagulants in atrial fibrillation: when and how? PACE 1994; 17(5): 1011-1015.
10. Van Gelder IC, Crijns ET, Wiek H et al. Efficacy and safety of flecainide in maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or flutter. Am J Cardiol 1989; 64: 1317-1321.
11. Gosselink ATM, Crijns HJG, van Gelder IC et al. Low dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA 1992; 267: 3289-3293.
12. Hohnloser SH, Arendts W, Quart B et al. Torsade de pointes during sotalol therapy. Eur Heart J 1992: 13(suppl): 305.
13. Coplen SE, Antman EM, Berlin JA et al. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomised control trials. Circulation 1990; 82(4): 1106-1116.
14. Flacker GC, Blackshear JL, Mcbride R et al. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992; 20: 527.
15. Gallagher JJ, Sevenson RH, Kasell JM. Catheter technique for closed chest ablation of atrioventricular conduction system: a therapeutic alternative for treatment of refractory supraventricular tachycardias. N Engl J Med 1982; 306: 194-200.
16. Evans G, Scheiman M, Zipes D et al. The percutaneous cardiac mapping and ablation registry: final summary of results. PACE 1988; 11: 1621-1626.
17. Huang SK, Bharati S, Graham AR et al. Closed chest catheter desiccation of atrioventricular junction using radiofrequency energy: a new method of catheter ablation. J Am Coll Cardiol 1987; 9: 349-358.
18. Jensen SM, Bergfeldt L, Rosenqvist M. Long-term follow-up of patients treated by radiofrequency ablation of atrioventricular junction. PACE 1995; 18(Pt 1): 1609-1614.
19. Heinz G, Siostrzonek P, Kreiner G et al. Improvements in left ventricular systolic function after successful radiofrequency his bundle ablation for drug refractory, chronic atrial fibrillation and recurrent atrial flutter. Am J Cardiol 1992; 69: 489-492.
20. Edner M, Caidahl K, Bergfeldt L et al. Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation. Br Heart J 1995; 74: 261-267.
21. Fleck RP, Chen PS, Boyce K et al. Radiofrequency modification of atrioventricular conduction by selective ablation of the low posterior septal right atrium in a patient with atrial fibrillation and rapid ventricular response. PACE 1993; 16: 377-381.
22. Bella PD, Tondo C, Riva S et al. Acute and medium term results of atrioventricular node modulation in patients with atrial fibrillation or flutter. PACE 1995; 18:4(2): 859.
23. Kreiner G, Heinz G, Gossinger H. Can selective slow pathway ablation effectiveiy reduce ventricular rate during atrial fibrillation. PACE 1995; 18: 4(2): 843.
24. Cox JL, Boineau JP, Scheussler RB et al. Five year experience with the maze procedure for atrial fibrillation. Ann Thorac Surg 1993; 56: 814-824.
25. Elvan A. Rigden LB, Kisanuki A et al. Radiofrequency catheter ablation of the atria effectively abolishes pacing induced chronic atrial fibrillation. PACE 1995; 18: 4(2): 856.
26. Rosenqvist M, Brandt J, Shuller H. Long-term pacing in sinus node disease: effect of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 1988; 116: 16-22.
27. Hesselson AB, Parsonnet V, Bernstein AD et al. Deleterious effects of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual-chamber pacing. J Am Coll Cardiol 1992; 19: 1542-1549.
28. Andersen HR, Thuesen L, Bagger JP et al. Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 1994; 344: 1523-1528.
29. Coumel P, Attuel P, Lavalle JP et al. Syndrome d'arythmie auriculaire d'origin vagale. Arch Mal Couer 1978: 71: 645-656.
30. Coumel P, Frioucourt P, Muciga J et al. Long-term prevention of vagal arrhythmias by atrial pacing at 90/min. PACE 1983; 6: 552-560.
31. Daubert C. Mabo P, Berder V et al. Permanent dual atrium pacing in major interatrial conduction blocks: a four year experience (abstract). PACE 1993; 16: 885.
32. Kirchhof CJ, Wijffels M, Allessie M. Pace termination of atrial fibrillation. In: Olsson SB, Ed. Atrial fibrillation: mechanism and therapetitic strategies. New York: Futura 1994: 251-269.
33. Dunbar DN, Tobler HG, Fetter J et al. Intracavitary electrode catheter cardioversion of atrial tachyarrhythmias in the dog. J Am Coll Cardial 1986; 7: 1015-1027.
34. Powell AC, Garon H, McGovern BA et al. Low energy conversion of atrial fibrillation in sheep. J Am Coll Cardiol 1992; 20: 707-711.
35. Cooper RAS, Alferness CA, Smith WM et al. Internal cardioversion of atrial fibrillation in sheep. Circulation 1993; 87: 1673-1686.
36. Kalman JM, Power JM, Chen JM et al. Importance of electrode design, lead configuration and impedance for successful low energy transcatheter atrial defibrillation in dogs. J Am Coll Cardiol 1993; 22: 1199-1206.
37. Nathan AW, Bexton RS, Spurrell RAJ. Internal transvenous low energy cardioversion for the treatment of cardiac arrhythmias. Br Heart J 1984; 52: 377-384.
38. Keane D, Sulke N, Cooke R et al. Endocardial cardioversion of atrial flutter and fibrillation (abstract). PACE 1993; 16: 928.
39. Alt E, Schmilt C, Ammer R et al. Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation. PACE 1994; 17(5): 1067-1077.
40. Murgatroyd FD, Johnson EE, Cooper RA et al. Safety of low energy transvenous atrial defibrillation: world experience. Circulation 1994; 90: 1-14.